PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Drug Discovery Research Takes a Leap Forward with Increasing Adoption of Electronic Lab Notebooks - New analysis from Frost & Sullivan, European Electronic Lab Notebooks (ELN) Markets, reveals that these markets earned revenues of $32.3 million in 2006 and estimates this to reach $143.1 million in 2013
Drug Discovery Research Takes a Leap Forward with Increasing Adoption of Electronic Lab Notebooks

 

NewswireToday - /newswire/ - London, United Kingdom, 2007/07/03 - New analysis from Frost & Sullivan, European Electronic Lab Notebooks (ELN) Markets, reveals that these markets earned revenues of $32.3 million in 2006 and estimates this to reach $143.1 million in 2013.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The European electronic lab notebooks (ELN) market is the scene of much change today as the technology continues to develop rapidly and become more refined with each passing day. Surpassing the capabilities of traditional bound laboratory notebooks, ELNs provide a sophisticated communications platform that enables researchers to share experiment-related information seamlessly, and even improve or reuse the data. It also satisfies multiple intellectual property and regulatory requirements, allowing significant reductions in cycle times in biopharmaceutical R&D.

“Frost & Sullivan expects to see continued and rapid growth from the specific ELN segment,” notes Frost & Sullivan Programme Leader of Drug Discovery Dr. Amarpreet Dhiman. “One of the key advances in ELN technology has been the ability to cater to niche end users with specific solutions that include features such as authentication, sign/witness, audit, notebook record repository and reporting services with extensive workflow customisation capabilities.”

New analysis from Frost & Sullivan (healthcareandlifesciencesIT.frost.com), European Electronic Lab Notebooks (ELN) Markets, reveals that these markets earned revenues of $32.3 million in 2006 and estimates this to reach $143.1 million in 2013.

If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the latest analysis of European Electronic Lab Notebooks (ELN) Markets, then send an email to Radhika Menon Theodore, Corporate Communications, at rmtheodore[.]frost.com with your full name, company name, title, telephone number, fax number and email address. Upon receipt of the above information, an overview will be sent to you by email.

Pharmaceuticals and biotechnology companies can now deploy an ELN platform across their entire R&D processes and gain dramatic improvements in productivity, collaboration and regulatory compliance. Although ELNs are by no means the only knowledge system in the drug development and life sciences chain, they are definitely a key link in the chain that allows end users to capture and share all the unique and proprietary information they generate.

However, many organisations are concerned about ELN affecting their processes and ways of working and this has impacted ELN adoption. The extent of changes that scientists would have to make if they invested in ELNs is considerable, and could range from training staff and adopting new processes to upgrading other systems to make them compatible with ELN. This is bound to lead to some amount of resistance from scientists, particularly since the traditional paper lab notebook has dominated the scientific environment for so many years.

“ELNs represent a potential solution for meeting the need of companies to protect their intellectual property and the needs of end users,” says Dr. Dhiman. “However, before they can be adopted by companies as the principal method of recording lab data, they must meet the reliability, authenticity and corroboration criteria established for paper laboratory notebooks.”

Security is a particularly important aspect of the ELN database, especially when entering and updating data in the ELN platform. The challenge is to maintain an audit trail during such updates and to provide suitable IT administration features to ensure effective and secure running of the system.

ELNs also need to have a high degree of flexibility that allows scientists from different disciplines to continue working in ways that best suit their needs. They need to be sufficiently structured to enable an ordered and managed approach to record-keeping and must also offer advanced search capabilities.

“Scientific requirements need to be appropriately articulated so that ELNs satisfy and accommodate the needs of all labs while simultaneously working more efficiently and effectively,” concludes Dr. Dhiman. “The European ELN market is expected to continue to grow rapidly over the next several years as ELNs move into the mainstream and developers continue to release application-specific solutions as well as develop a host of interfaces for other add-ons fulfilling end-user demands.”

European Electronic Lab Notebooks (ELN) Markets is part of the Healthcare and Life Sciences IT Growth Partnership Service program, which also includes research in the following: Virtual Screening Opportunities in Drug Discovery in Europe, European Bioinformatics Markets, and Data Integration in Life Science Companies. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Drug Discovery Research Takes a Leap Forward with Increasing Adoption of Electronic Lab Notebooks

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Radhika Menon Theodore 
+91 44 42044541 rmtheodore[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove
GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
Insulin Delivery Devices Market Size to Expand at 7% CAGR through 2020 Says PMR
Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)